疏血通联合阿托伐他汀在糖尿病肾病患者中的应用

Shuxuetong combined with atorvastatin in the treatment of diabetic nephropathy

目的探究疏血通联合阿托伐他汀治疗糖尿病。肾病的临床疗效。方法选取确诊为糖尿病肾病的患者60例，将其随机分为实验组30例和对照组30例；实验组在常规基础治疗基础上采用疏血通联合阿托伐他汀进行治疗，对照组在常规基础治疗的基础上单纯采用阿托伐他汀进行治疗。结果实验组和对照组血糖治疗后均明显优于治疗前（P〈0．05）；两组患者治疗后血糖值比较差异无统计学意义（P〉0．05）；实验组相关检测指标以及疗效评价情况均明显优于对照组（P〈0．05）。结论疏血通联合阿托伐他汀可以明显减少患者尿蛋白量，改善患者肾功能，提高糖尿病肾病病人的生活质量。

Objective To explore the clinical efficacy of combination therapy with Shuxuetong and atorvastatin for patients with diabetic nephropathy. Methods 60 patients with diabetic nephropathy were randomly divided into a study group and a control group, 30 for each group. In addition to conventional treatment, the study group received Shuxuetong combined with atorvastatin, while the control group received atorvastatin alone. Results After treatment, levels of glucose was better than the baseline levels in both groups （P〈0.05）; glucose level did not differ significantly between the two groups （P〉0.05）. The study group was superior to the control group in the related test results and efficacy evaluation （P〈0.05）. Conclusions Combination therapy with Shuxuetong and atorvastatin can significantly lower the amount of urinary, protein, improve renal function, and increase quality of life in patients with diabetic nephropathy.